Perfusion System Market Analysis By Technology (Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Organ Type (Heart, Lung, Kidney, Liver), And Segment Forecasts, 2014 - 2025

The global perfusion systems market is expected to reach USD 183.8 million by 2025, according to a new report by Grand View Research, Inc. Rising demand for transplantation owing to increased incidence of vital organ failures is a major growth driver of the market. To curb this problem, Machine Perfusion (MP) is adopted by clinics. Hence, demand for the same is expected to grow over the coming years.
Statistics published by the National Kidney Foundation in 2014 states that 4,761 patients died due to unavailability of a kidney. This showcases the need for viable donated organs for transplantation, thereby boosting market growth.
The introduction of technologically advanced products for the purpose of enhanced efficiency and cost-effectiveness is expected to serve this market with lucrative opportunities. For instance, introduction of portable organ perfusion systems is presumed to gain popularity over the coming years owing to associated benefits with its usage such as ease of access, cost-efficiency, and portability.
Market participants are involved in extensive R&D for development of innovative perfusion techniques. For instance, TransMedics, Inc. carried out the world’s first warm blood perfusion liver transplantation with its innovative TransMedics Organ Care System Liver technology.
Moreover, many of market players in the U.S. and Europe are involved in the development of new products that are in clinical trials. For example, METRA developed by OrganOx Ltd. for automatic liver transportation and normothermic liver perfusion is under clinical study in the U.S. The expected product approvals in the coming years are anticipated to serve this industry with lucrative growth opportunities.
Further Key Findings From the Study Suggest:
‧ Presence of government initiatives such as National Organ Transplant Programme in India and initiatives from nonprofit organizations such as Donate Life America in the U.S. are contributing toward increasing awareness level
‧ Introduction of warm blood perfusion technology is expected to offer this industry with future growth opportunities
‧ Hypothermic MP held the dominant share as of 2016 owing to increasing adoption for kidney preservation. These systems are capable of preserving an organ for a longer duration as compared to static cold storage. The associated benefits with the use of this technology is expected to fuel the demand
‧ The MP technology for kidney transplantation segment held a dominant share as of 2016 owing to benefits attached to its usage
‧ As of now, there are two MP systems that are approved by the U.S. FDA including LifePort Kidney Transporter by Organ Recovery Systems Inc. and WAVES RM3 by Waters Medical Systems
‧ The Asia Pacific regional industry for MP is expected to witness lucrative CAGR during the forecast period
‧ The industry participants are focusing toward the development of cost-effective solutions, thereby increasing R&D activities for the development of novel technologies

Table of Contents
Chapter 1 Research Methodology
1.1 Country wise Market: Base Estimates
1.2 Global market: CAGR Calculation
1.3 Region Based Segment Share Calculation
1.4 Research Scope & Assumptions
1.5 List of Data Sources
1.5.1 Data for primary interviews, by sources
1.5.2 Data for primary interviews, by region
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Organ Perfusion Systems Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increasing demand for organ transplantation
3.2.2 Technological advancements
3.2.3 Increasing initiatives to promote organ donation
3.3 Market Restraint Analysis
3.3.1 High cost of devices
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by technology
3.5 Organ Perfusion Systems - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s
Chapter 4 Organ Perfusion Systems: Technology Estimates & Trend Analysis
4.1 Organ Perfusion Systems Market: Technology Movement Analysis
4.2 Hypothermic Machine Perfusion
4.2.1 Hypothermic machine perfusion market, 2014 - 2025 (USD Million)
4.3 Normothermic Machine Perfusion
4.3.1 Normothermic machine perfusion market, 2014 - 2025 (USD Million)
Chapter 5 Organ Perfusion Systems: Organ Type Estimates & Trend Analysis
5.1 Organ Perfusion Systems Market: Organ Type Movement Analysis
5.2 Heart
5.2.1 Heart market, 2014 - 2025 (USD Million)
5.3 Lung
5.3.1 Lung market, 2014 - 2025 (USD Million)
5.4 Kidney
5.4.1 Kidney market, 2014 - 2025 (USD Million)
5.5 Liver
5.5.1 Liver Market, 2014 - 2025 (USD Million)
5.6 Others
5.6.1 Others Market, 2014 - 2025 (USD Million)
Chapter 6 Organ Perfusion Systems: Regional Estimates & Trend Analysis, by Technology, and Organ Type
6.1 Organ Perfusion Systems Market Share by Region, 2016& 2025
6.2 North America
6.2.1 North America organ perfusion systems market, by country, 2014 - 2025 (USD Million)
6.2.2 North America organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.2.3 North America organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.2.4 U.S.
6.2.4.1 U.S. organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.2.4.2 U.S. organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.2.5 Canada
6.2.5.1 Canada organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.2.5.2 Canada organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.3 Europe
6.3.1 Europe organ perfusion systems market, by country, 2014 - 2025 (USD Million)
6.3.2 Europe organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.3.3 Europe organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.3.4 Germany
6.3.4.1 Germany organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.3.4.2 Germany organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.3.5 UK
6.3.5.1 UK organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.3.5.2 UK organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific organ perfusion systems market, by country, 2014 - 2025 (USD Million)
6.4.2 Asia Pacific organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.4.3 Asia Pacific organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.4.4 Japan
6.4.4.1 Japan organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.4.4.2 Japan organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.4.5 China
6.4.5.1 China organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.4.5.2 China organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.4.6 India
6.4.6.1 India organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.4.6.2 India organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America organ perfusion systems market, by country, 2014 - 2025 (USD Million)
6.5.1.1 Latin America organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.5.1.2 Latin America organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.5.2.2 Brazil organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.5.3.2 Mexico organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.6 MEA
6.6.1 MEA organ perfusion systems market, by country, 2014 - 2025 (USD Million)
6.6.2 MEA organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.6.3 MEA organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
6.6.4 South Africa
6.6.4.1 South Africa organ perfusion systems market, by technology, 2014 - 2025 (USD Million)
6.6.4.2 South Africa organ perfusion systems market, by organ type, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market Participation
7.3 Company Profiles
7.3.1 XVIVO Perfusion AB
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Organ Assist B.V.
7.3.2.1 Company overview
7.3.2.2 Product benchmarking
7.3.2.3 Strategic initiatives
7.3.3 Organ Recovery Systems, Inc
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Organ Transport Systems, Inc.
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Waters Medical Systems LLC
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Paragonix Technologies, Inc.
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 TransMedics, Inc.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 OrganOx Limited
7.3.8.1 Company overview
7.3.8.2 Product benchmarking
7.3.8.3 Strategic initiatives
7.3.9 Preservation Solutions Inc
7.3.9.1 Company overview
7.3.9.2 Product benchmarking
7.3.9.3 Strategic initiatives
7.3.10 Bridge to Life Ltd.
7.3.10.1 Company overview
7.3.10.2 Product benchmarking
7.3.10.3 Strategic initiatives